MedPath

DOTERRA AUSTRALIA PTY LTD

🇦🇺Australia
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

39

TGA:39

Drug Approvals

Lavender Peace Softgels (489563)

Product Name
Lavender Peace Softgels
Approval Date
May 22, 2025
TGA

doTERRA MetaPWR Advantage (485226)

Product Name
doTERRA MetaPWR Advantage
Approval Date
Apr 4, 2025
TGA

xEO Mega (458334)

Product Name
xEO Mega
Approval Date
Aug 2, 2024
TGA

doTERRA On Guard+ (441290)

Product Name
doTERRA On Guard+
Approval Date
Feb 16, 2024
TGA

doTERRA On Guard+ (414415)

Product Name
doTERRA On Guard+
Approval Date
Jul 24, 2023
TGA

doTERRA MetaPWR Assist (407530)

Product Name
doTERRA MetaPWR Assist
Approval Date
Apr 12, 2023
TGA

doTERRA MetaPWR Advantage (406708)

Product Name
doTERRA MetaPWR Advantage
Approval Date
Mar 23, 2023
TGA

Microplex VMz (395530)

Product Name
Microplex VMz
Approval Date
Sep 6, 2022
TGA

Ice Blue Polyphenol Complex (393957)

Product Name
Ice Blue Polyphenol Complex
Approval Date
Aug 16, 2022
TGA

DigestZen Softgels (393654)

Product Name
DigestZen Softgels
Approval Date
Aug 9, 2022
TGA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.